Argent BioPharma Statistics
Total Valuation
RGTLF has a market cap or net worth of 4.56 million. The enterprise value is 10.12 million.
| Market Cap | 4.56M |
| Enterprise Value | 10.12M |
Important Dates
The last earnings date was Thursday, May 29, 2025.
| Earnings Date | May 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 72.18M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +284.88% |
| Shares Change (QoQ) | -0.50% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 27.70M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 24.90 |
| PB Ratio | -0.68 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.72 |
| EV / Sales | 53.10 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.47 |
Financial Position
The company has a current ratio of 0.16
| Current Ratio | 0.16 |
| Quick Ratio | 0.08 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.84 |
| Interest Coverage | -422.13 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -121.60% |
| Return on Invested Capital (ROIC) | -282.13% |
| Return on Capital Employed (ROCE) | 195.82% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.03 |
| Inventory Turnover | 0.86 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -58.50% in the last 52 weeks. The beta is 0.50, so RGTLF's price volatility has been lower than the market average.
| Beta (5Y) | 0.50 |
| 52-Week Price Change | -58.50% |
| 50-Day Moving Average | 0.25 |
| 200-Day Moving Average | 3.59 |
| Relative Strength Index (RSI) | 43.43 |
| Average Volume (20 Days) | 70,017 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, RGTLF had revenue of 183,076 and -14.00 million in losses. Loss per share was -0.28.
| Revenue | 183,076 |
| Gross Profit | -232,651 |
| Operating Income | -12.28M |
| Pretax Income | -14.00M |
| Net Income | -14.00M |
| EBITDA | -11.64M |
| EBIT | -12.28M |
| Loss Per Share | -0.28 |
Balance Sheet
The company has 444,574 in cash and 5.79 million in debt, giving a net cash position of -5.34 million.
| Cash & Cash Equivalents | 444,574 |
| Total Debt | 5.79M |
| Net Cash | -5.34M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -6.73M |
| Book Value Per Share | -0.12 |
| Working Capital | -6.90M |
Cash Flow
In the last 12 months, operating cash flow was -6.83 million and capital expenditures -77,685, giving a free cash flow of -6.90 million.
| Operating Cash Flow | -6.83M |
| Capital Expenditures | -77,685 |
| Free Cash Flow | -6.90M |
| FCF Per Share | n/a |
Margins
| Gross Margin | -127.08% |
| Operating Margin | -6,705.91% |
| Pretax Margin | -7,644.92% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
RGTLF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -284.88% |
| Shareholder Yield | n/a |
| Earnings Yield | -307.01% |
| FCF Yield | -151.45% |
Stock Splits
The last stock split was on October 30, 2023. It was a reverse split with a ratio of 0.001.
| Last Split Date | Oct 30, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.001 |
Scores
RGTLF has an Altman Z-Score of -89.9. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -89.9 |
| Piotroski F-Score | n/a |